Afghanistan vs Republic of Korea: Cases started on MDR-TB treatment
Afghanistan
464
in 2024
Republic of Korea
461
in 2024
Afghanistan rank
30th
Republic of Korea rank
31st
Cases started on MDR-TB treatment over time
- Afghanistan
- Republic of Korea
How they compare
Afghanistan currently reports 464 against 461 in Republic of Korea, a difference of 3.
The two have swapped places 3 times across 14 shared years of data; in 2011 it was Republic of Korea ahead.
Afghanistan ranks 30th and Republic of Korea ranks 31st of 193 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 149.22 | 835.78 | 686.56 | Republic of Korea |
| 2020s | 464.8 | 562 | 97.2 | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Afghanistan or Republic of Korea?
- Afghanistan, at 464 against 461 in Republic of Korea as of 2024.
- What is the difference in cases started on mdr-tb treatment between Afghanistan and Republic of Korea?
- 3, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Republic of Korea?
- 14 years are reported by both, from 2011 to 2024.
- How do Afghanistan and Republic of Korea rank globally for cases started on mdr-tb treatment?
- Afghanistan ranks 30th and Republic of Korea ranks 31st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.